INFUSION AND INJECTION SOLUTION OF LEVODOPA

摘要

An infusion or injection solution of Levodopa containing at least 10 mg/mL of
Levodopa, or at least 5 mg/mL of Levodopa together with at least 0.5 mg/mL of
at least one inhibitor of a Levodopa-metabolising enzyme is disclosed. The
solution further contains a buffer, a physiologically acceptable sugar, such
as glucose, a physiologically acceptable acid, such as hydrochloric acid, and
optionally a stabilizer, and has a pH of lower than or equal to 6. There are
also described a disposable syringe containing an infusion or injection
solution of Levodopa, optionally together with a Levodopa-metabolising enzyme,
and an infusion pumpcassette containing an infusion or injection solution of
Levodopa optionally together with a Levodopa-metabolising enzyme.